Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Sector news
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
Delayed Bourse de Toronto  -  02:05:53 2023-02-01 pm EST
0.1500 CAD   -3.23%
01/19Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia
MT
01/19Khiron begins dispensation of insurance-covered prescriptions in Colombia
PR
01/16Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Alternative Medicine
02/01Buchang Pharmaceuticals Unit Gets Production License from Chinese Provincial Drug Regul..
MT
01/30Dong-E-E-Jiao Expects Up to 810 Million Yuan in 2022 Profit; Shares Rise 4%
MT
01/30Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022
CI
01/20Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance..
MT
01/08Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Dr..
MT
01/03Gloom and boom: Fund managers' top picks for 2023
RE
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Appoints Mao Weiwen as Non..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Won..
CI
2022Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results
MT
2022China stocks jump on easing COVID curbs
RE
2022China stocks rise on further eased COVID rules
RE
2022Shijiazhuang Yiling Pharma Secures Regulatory Nod For Traditional Chinese Medicine Tria..
MT
2022Yiling Pharma Denies Claims That COVID-19 Drug May Cause Liver Injury
MT
2022Shijiazhuang Yiling Pharmaceutical's Anti-Respiratory Disease Drug Enters Singaporean M..
MT
2022China stocks retreat on concerns of surging COVID cases
RE
2022China stocks retreat on concerns of rising COVID cases
RE
2022Investors bet on greed and fear as China loosens COVID grip
RE
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Yiling to Boost Production of Traditional Herbal Medicine for Flu; Shares Rally 7%
MT
2022Chinese rush to stock up antigen kits, medicines as COVID prevention curbs ease
RE
2022Shandong Buchang Pharmaceuticals Unit Gets Registration Certificate for Anti-Lung Disea..
MT
2022Buchang Pharmaceutical's Lung Detoxifying Drug Gets Extension of Validity to 24 Months
MT
2022China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
2022China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
2022Yiling Pharma Seeks Clinical Trial of Chinese Medicine Against Colds; Shares Rally 5%
MT
2022Tianjin Pharmaceutical Profit Jumps 31% in Q3 on Higher Revenue
MT
2022Dong-E-E-Jiao's January-September Profit Increases; Stock Rises 4%
MT
2022Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Z..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mont..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2022China Resources Angde Bio-Pharmaceutical Co., Ltd. announced that it expects to receive..
CI
2022Dong-E-E-Jiao Sees Nine-Month to September Profit Rise Up to 86%
MT
2022Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Nine Months Ended 30 S..
CI
2022Buchang Pharmaceuticals Cleared to Launch Clinical Trial of Cancer Drug
MT
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire addition..
CI
2022Tianjin Pharmaceutical to Buy Controlling Stake in NewScen Coast Bio for $6 Million
MT
2022NewScen Coast Bio-Pharmaceutical Co., Ltd announced that it expects to receive CNY 43.2..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2022UBS Adjusts Dong-E E-Jiao's Price Target to 40.75 Yuan From 39.30 Yuan, Keeps at Neutra..
MT
2022Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Dong-E-E-Jiao Co.,Ltd. Announces Cash Dividend for the Year 2021, Payable on August 23,..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f..
CI
2022Changrui Biotechnology Co., Ltd. announced that it expects to receive CNY 64 million in..
CI
2022Tianjin Zhongxin Board OKs Use of $52 Million Placement Proceeds
MT
2022Shandong Dongxin Investment Co., Ltd. announced that it expects to receive CNY 180 mill..
CI
2022Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2022
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Final Dividend on Share A for 20..
CI
2022Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2021
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Final Dividend for..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for ..
CI
2022Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
2022Tianjin Zhongxin Pharmaceutical Posts Lower Profit in January-March
MT
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year ..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Zhang Yu as Chief P..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2022Dong-E-E-Jiao's Profit, Revenue Rise in Q1; Shares Jump 5%
MT
2022Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021
CI
2022Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy
MT
2022Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Three Months Ended 31 March 2..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Recommends to Declare Divide..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2022UBS Adjusts Dong-E-E-Jiao's Price Target to 39.3 Yuan From 37.5 Yuan, Keeps at Neutral
MT
2022Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend as of 31 December 2021
CI
2022Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 20..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year End..
CI
2022Dong-E-E-Jiao Expects Higher Profit in 2021
MT
2022Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Tianjin Zhongxin Pharmaceutical Elects New Chairman; Shares Slip 3%
MT
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Election of Ms. Zha..
CI
2021Dong-E-E-Jiao Swings to Profit in January-September
MT
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Mr. Xing Jianhua as..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Ms. Zhang Mingrui a..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Resignation of Tan..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical..
CI
2021Dong E E Jiao : Forecasts Up to 164% Surge in Q3 Profit
MT
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
2021Tianjin Zhong Xin Pharmaceutical : Zhongxin Board OKs U..
MT
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Appointment of Guo ..
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
Upcoming event on KHIRON LIFE SCIENCES CORP.